NirogGyan™ shows up in
42%
NirogGyan™ appears in 0% of buyer questions and 100% of direct comparison questions that include NirogGyan™. 1mg appears in 17% of buyer questions.
AI search report
See where NirogGyan™ is losing buyers in AI search
See when AI mentions NirogGyan™, where buyer questions leave you out, and what to fix first so more buyers discover you before competitors.
What buyers see in AI search
What AI says before buyers reach NirogGyan™'s site
Buyer questions missed
58%
NirogGyan™ is left out of 58% of the buyer and comparison questions checked.
Who AI recommends instead
1mg
1mg is the competitor AI surfaces most often here.
Where AI already picks you
AI does not consistently connect NirogGyan™ with a clear reason buyers would choose it yet. That usually means the evidence buyers need is either missing, scattered, or easier to find on competitor sites.
Where competitors beat you
- Competitors beat NirogGyan™ on Abnormal Value Highlighting. Practo is rated moderate while NirogGyan™ is limited.
- Competitors beat NirogGyan™ on Nlp/ml Capabilities. 1mg is rated moderate while NirogGyan™ is limited.
- Competitors beat NirogGyan™ on Plain-language Summaries. 1mg is rated moderate while NirogGyan™ is limited.
How AI describes you vs competitors
What AI connects each brand with
| What buyers care about | What this means | NirogGyan™ | 1mg | Practo |
|---|---|---|---|---|
| Customer support | AI has little clear evidence connecting NirogGyan™ with customer support. | Barely associated | Barely associated | Barely associated |
| Integrations | AI has little clear evidence connecting NirogGyan™ with integrations. | Barely associated | Barely associated | Barely associated |
| Pricing | AI gives 1mg more credit for pricing than NirogGyan™. | Barely associated | Sometimes associated | Barely associated |
| Plain-language Summaries | AI gives 1mg more credit for plain-language summaries than NirogGyan™. | Barely associated | Sometimes associated | Barely associated |
| Abnormal Value Highlighting | AI gives Practo more credit for abnormal value highlighting than NirogGyan™. | Barely associated | Barely associated | Sometimes associated |
| Nlp/ml Capabilities | AI gives 1mg more credit for nlp/ml capabilities than NirogGyan™. | Barely associated | Sometimes associated | Barely associated |
Buyer questions you are missing
The questions where buyers may never see NirogGyan™
These are high-intent questions where AI did not mention NirogGyan™. Each one can become a clear answer page AI can trust and reuse, supported by evidence from NirogGyan™'s site.
Buyer question
best software to simplify medical lab reports for patients in India
NirogGyan™ was not mentioned in this AI answer.
See the AI answerBuyer question
SaaS platform for automated medical report interpretation for diagnostic labs
NirogGyan™ was not mentioned in this AI answer.
See the AI answerBuyer question
how to explain pathology reports to patients in simple language using AI
NirogGyan™ was not mentioned in this AI answer.
See the AI answerBuyer question
hospital patient report simplification tool India pricing
NirogGyan™ was not mentioned in this AI answer.
See the AI answerBuyer question
healthcare analytics software for converting complex test results into easy summaries
NirogGyan™ was not mentioned in this AI answer.
See the AI answerBuyer question
cloud based solution for diagnostic centers to auto generate patient friendly health reports India
NirogGyan™ was not mentioned in this AI answer.
See the AI answerWhat to fix first
The shortest path to better AI search presence
Readable turns missed buyer questions into pages AI can trust, clearer evidence buyers can verify, and comparison answers that make it easier for AI tools to recommend you.
Close the Abnormal Value Highlighting gap before competitors keep winning the recommendation.: Buyers are asking about Abnormal Value Highlighting, but your homepage barely explains it. AI answers currently connect Practo more strongly with that need.
Publish dedicated comparison landing pages targeting 'NirogGyan vs Innovaccer,' 'NirogGyan vs Healthplix,' and 'NirogGyan vs 1mg for diagnostic labs' with structured data markup, so AI assistants can index NirogGyan™ as a named alternative in unprompted category queries—not just when directly prompted.
Create indexable, citation-ready content (technical docs, case studies, G2/Capterra profiles) that explicitly associates NirogGyan™ with the attributes AI assistants use to evaluate this category: NABH compliance, DPDP Act data residency, LIS/LIMS API integration, multilingual summaries, and per-report pricing—so these attributes surface in AI-generated feature comparisons.
Secure third-party citations on healthcare IT analyst sites, Indian healthtech directories, and NABH/NHA-adjacent publications that position NirogGyan™ within the 'patient report simplification' and 'diagnostic lab analytics' category frames, giving AI assistants the source authority needed to recommend it in unprompted buyer queries alongside Innovaccer and Healthplix.
The query '1mg vs Practo medical report simplification features for healthcare providers' surfaces both competitors without mentioning NirogGyan™, representing a direct gap in provider-segment comparison coverage where NirogGyan™'s white-label API and diagnostic lab focus would be highly relevant.
What you’ll see in the AI search review
Find the AI answers costing you buyers
In one review, we’ll show where NirogGyan™ is missing, which competitors AI is recommending instead, and the first pages or evidence updates most likely to help you show up.
The buyer questions where NirogGyan™ is left out.
The competitor claims AI is repeating instead.
The first fixes most likely to help NirogGyan™ show up.
Fix the buyer moments AI is missing
We’ll show you which AI answers are costing you buyers and what to publish first.
Bring this report to a short review with Readable. You will leave knowing the buyer questions, evidence gaps, and answer pages that matter most.
Improve my AI visibility